Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Sep;35(9):1868–1874. doi: 10.1128/aac.35.9.1868

Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group.

E J Goldstein 1, D M Citron 1, C E Cherubin 1
PMCID: PMC245283  PMID: 1952860

Abstract

We compared the inoculum effects for 109 recent clinical isolates of the Bacteroides fragilis group of cefoxitin, cefotetan, ceftizoxime, ceftriaxone, and three beta-lactamase inhibitors (clavulanic acid, sulbactam, and tazobactam) and their penicillin-derived components. Bactericidal activity was assayed and morphologic changes were monitored for selected strains exhibiting a large inoculum effect. Ceftizoxime demonstrated the largest inoculum effect, followed by cefotetan and ceftriaxone. The large inoculum effect of ceftizoxime and ceftriaxone was correlated with filamentous transformation at the high inoculum (10(8) CFU/ml) and lack of bactericidal activity suggesting drug destruction or inactivation. Cefotetan was bactericidal for B. fragilis isolates but not for other members of the B. fragilis group. Cefoxitin showed the least inoculum effect and was consistently bactericidal at high (10(8) CFU/ml), standard (10(6) CFU/ml), and low (10(4) CFU/ml) inocula, followed by ampicillin-sulbactam. Piperacillin-tazobactam and ticarcillin-clavulanic acid showed an intermediate inoculum effect. The degree of inoculum effect observed generally correlated with bactericidal activity at all inocula.

Full text

PDF
1868

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldridge K. E., Henderberg A., Sanders C. V. Enhanced antimicrobial activity of old and new beta-lactams against cefoxitin-resistant Bacteroides fragilis group isolates by beta-lactamase inhibitors. J Antimicrob Chemother. 1990 May;25(5):873–875. doi: 10.1093/jac/25.5.873-a. [DOI] [PubMed] [Google Scholar]
  2. Aldridge K. E., Sanders C. V. Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates. J Clin Microbiol. 1987 Dec;25(12):2317–2321. doi: 10.1128/jcm.25.12.2317-2321.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aldridge K. E., Sanders C. V., Marier R. L. Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria. J Antimicrob Chemother. 1986 Apr;17(4):463–469. doi: 10.1093/jac/17.4.463. [DOI] [PubMed] [Google Scholar]
  4. Aldridge K. E., Wexler H. M., Sanders C. V., Finegold S. M. Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology. Antimicrob Agents Chemother. 1990 Jan;34(1):179–181. doi: 10.1128/aac.34.1.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Appelbaum P. C., Philippon A., Jacobs M. R., Spangler S. K., Gutmann L. Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance. Antimicrob Agents Chemother. 1990 Nov;34(11):2169–2176. doi: 10.1128/aac.34.11.2169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Borobio M. V., Pascual A., Dominguez M. C., Perea E. J. Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria. Antimicrob Agents Chemother. 1986 Oct;30(4):626–627. doi: 10.1128/aac.30.4.626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brook I. Inoculum effect. Rev Infect Dis. 1989 May-Jun;11(3):361–368. doi: 10.1093/clinids/11.3.361. [DOI] [PubMed] [Google Scholar]
  8. Bulger R. R., Washington J. A., 2nd Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species. Antimicrob Agents Chemother. 1980 Mar;17(3):393–396. doi: 10.1128/aac.17.3.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Citron D. M., Baron E. J., Finegold S. M., Goldstein E. J. Short prereduced anaerobically sterilized (PRAS) biochemical scheme for identification of clinical isolates of bile-resistant Bacteroides species. J Clin Microbiol. 1990 Oct;28(10):2220–2223. doi: 10.1128/jcm.28.10.2220-2223.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cuchural G. J., Jr, Tally F. P., Jacobus N. V., Cleary T., Finegold S. M., Hill G., Iannini P., O'Keefe J. P., Pierson C. Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group. Antimicrob Agents Chemother. 1990 Mar;34(3):479–480. doi: 10.1128/aac.34.3.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eng R. H., Cherubin C., Smith S. M., Buccini F. Inoculum effect of beta-lactam antibiotics on Enterobacteriaceae. Antimicrob Agents Chemother. 1985 Nov;28(5):601–606. doi: 10.1128/aac.28.5.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gisby J., Beale A. S. Comparative efficacies of amoxicillin-clavulanic acid and ampicillin-sulbactam against experimental Bacteroides fragilis-Escherichia coli mixed infections. Antimicrob Agents Chemother. 1988 Dec;32(12):1830–1833. doi: 10.1128/aac.32.12.1830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goldstein E. J., Citron D. M. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group. J Clin Microbiol. 1988 Nov;26(11):2361–2366. doi: 10.1128/jcm.26.11.2361-2366.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Goldstein E. J., Citron D. M., Cherubin C. E. Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations. Antimicrob Agents Chemother. 1991 Mar;35(3):560–566. doi: 10.1128/aac.35.3.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jones R. N., Pfaller M. A., Fuchs P. C., Aldridge K., Allen S. D., Gerlach E. H. Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains. Diagn Microbiol Infect Dis. 1989 Nov-Dec;12(6):489–494. [PubMed] [Google Scholar]
  16. Lamothe F., Auger F., Lacroix J. M. Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group. Antimicrob Agents Chemother. 1984 May;25(5):662–665. doi: 10.1128/aac.25.5.662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Soriano F., Ponte C., Santamaría M., Castilla C. Effect of Bacteroides fragilis on mortality induced by Escherichia coli in an experimental infection treated with cefotaxime, aztreonam or gentamicin. J Antimicrob Chemother. 1989 Mar;23(3):383–388. doi: 10.1093/jac/23.3.383. [DOI] [PubMed] [Google Scholar]
  18. Sutter V. L., Kirby B., Finegold S. M. In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria. Rev Infect Dis. 1979 Jan-Feb;1(1):218–223. doi: 10.1093/clinids/1.1.218. [DOI] [PubMed] [Google Scholar]
  19. Wexler H. M., Reeves D., Finegold S. M. Effect of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strains. Clin Ther. 1989 Nov-Dec;11(6):828–833. [PubMed] [Google Scholar]
  20. Yu P. K., Washington J. A., 2nd Bactericidal activities of new beta-lactam antibiotics against Bacteroides fragilis. Antimicrob Agents Chemother. 1983 Jul;24(1):1–4. doi: 10.1128/aac.24.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES